Work

A prospective phase II trial of the listeria-based human papillomavirus immunotherpay axalimogene filolisbac in second- and third-line metastatic cervical cancer: A NRG oncology group trial

Year: 2017

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2017.03.506

Authors: W. Huh, W.E. Brady, D.S. Dizon, M.A. Powell, L.M. Landrum, C.A. Leath, E.J. Tanner, R.V. Higgins, S.M. Ueda, M.T. McHale, C. Aghajanian

Institutions: University of Alabama at Birmingham, Harvard University, Massachusetts General Hospital, Washington University in St. Louis, University of Oklahoma, Johns Hopkins Hospital, Carolinas Medical Center, Levine Cancer Institute, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Diego, Moores Cancer Center, Weill Cornell Medicine

Language: English

Topic: Cervical Cancer and HPV Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2621617146

FWCI: 2.055

Cites:

Cited by: 18

Related to: 10